NCT02874066 - PrOD for Non-Cirrhotic Patients With HCV-1b Receiving Hemodialysis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 13, 2017

Primary Completion Date

October 30, 2018

Study Completion Date

December 25, 2018

Conditions

Hepatitis Viruses

Interventions

DRUG

PTV/r/OBV/DSV

Viekirax/Exviera for 12 weeks

Trial Locations (8)

Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi City

National Taiwan University Hospital, Yun-Lin Branch, Douliu

China Medical University Hospital, Taichung

Taichung Veterans General Hospital, Taichung

National Cheng Kung University Hospital, Tainan City

National Taiwan University Hospital, Taipei

Taipei City Hospital, Ren-Ai Branch, Taipei

Tri-Service General Hospital, National Defense Medical Center, Taipei